EUVIMEDEUVIMED entdecken
Crossref

The effect of statin medication on the incidence of oral squamous cell carcinoma among betel‐nut chewers

Chun-Chi Huang, Wan-Ming Chen, Ben-Chang Shia, Mingchih Chen, Szu-Yuan Wu iD

Head & Neck · 2023

DOI: 10.1002/hed.27358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Chun-Chi Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study examines the relationship between statin use and oral cancer squamous cell carcinoma (OCSCC) risk in a cohort of 47 942 betel nut chewers.

Methods

The study used individual 1:1 matching and propensity score matching to compare statin users and nonusers.

Results

The incidence rate of OCSCC was significantly lower in statin users compared to nonusers (17.12 vs. 26.75 per 10 000 person‐years), yielding an incidence rate ratio of 0.64. After adjusting for confounders, statin use was associated with a reduced risk of OCSCC (adjusted hazard ratio: 0.61; 95% confidence interval: 0.52–0.71). A dose–response relationship was observed, with a significant reduction in OCSCC incidence when the cumulative defined daily dose of statin use was equal to or greater than Q3. The risk of OCSCC was lower among users of both hydrophilic and lipophilic statins.

Conclusion

This study provides evidence that statin use is associated with a reduced risk of OCSCC in betel nut chewers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsCarcinoma, Squamous CellHead and Neck NeoplasmsHumansArecaIncidenceSquamous Cell Carcinoma of Head and NeckNuts

Stichwörter der Autor:innen

OCSCCbetel nut chewingdose-responseincidence riskstatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.
  • Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan.
  • Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.
  • Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan.
  • Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.
  • Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan.

ORCID-Profile: Szu-Yuan Wu

Zitieren

APA

Huang, C. C., Chen, W. M., Shia, B. C., Chen, M., & Wu, S. Y. (2023). The effect of statin medication on the incidence of oral squamous cell carcinoma among betel‐nut chewers. Head & Neck. https://doi.org/10.1002/hed.27358

Vancouver

Huang CC, Chen WM, Shia BC, Chen M, Wu SY. The effect of statin medication on the incidence of oral squamous cell carcinoma among betel‐nut chewers. Head & Neck. 2023. doi:10.1002/hed.27358

BibTeX
@article{Huang2023,
  author = {Huang, Chun-Chi and Chen, Wan-Ming and Shia, Ben-Chang and Chen, Mingchih and Wu, Szu-Yuan},
  title = {The effect of statin medication on the incidence of oral squamous cell carcinoma among betel‐nut chewers},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27358}
}
Kostenlos starten →